Avricore Health’s HealthTab™ Endorsed by Ontario Pharmacists Association for Real-Time COVID-19 Data Reporting in Community Pharmacies
November 23, 2020 07:55 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) and the Ontario Pharmacists Association (OPA) are pleased to announce the expansion of their...
New Research Reveals Gazelle Diagnostic Device Outperformed Rapid Diagnostic Test for P. Vivax Malaria, Detected Challenging Types of Malaria, and Provided Affordable Sickle Cell Disease Detection
November 16, 2020 16:10 ET
|
Hemex Health
PORTLAND, Ore., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Hemex Health, an innovator in point-of-care diagnostic technologies, announced today that researchers will present five scientific posters at the...
NIH Awards Prize to Hemex Health’s Non-Invasive Sickle Cell, Malaria, Anemia Rapid Test (“SMART”) Diagnostic Technology
October 26, 2020 08:00 ET
|
Hemex Health
PORTLAND, Ore., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Researchers from Hemex Health, Medtronic plc, Case Western Reserve University, and the University of Nebraska Medical Center’s International...
Avricore Health Announces $1.5 Million Financing
October 14, 2020 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Oct. 14, 2020 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces a non-brokered private placement of up to 15,000,000 units...
HealthTab™ Integrating New Device to Add HbA1c Blood Glucose Testing to Its Real-Time Data Reporting System
September 22, 2020 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore" or the "Company") is pleased to announce the signing of a Letter of Intent...
Avricore Health’s HealthTab™ to Enable Real Time Reporting of COVID-19 Results in Pharmacy
September 09, 2020 08:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore" or the "Company") a leader in pharmacy-based point-of-care testing...
Avricore Health Corporate Update: Diversifies Revenues During COVID-19
June 29, 2020 09:44 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 29, 2020 (GLOBE NEWSWIRE) -- Avricore Health (TSXV: AVCR), like so many other business, has faced both challenges and opportunities over the past several weeks. ...
Point of Care (POC) Molecular Diagnostics Market Worth $2.39 Billion by 2027, Growing at a CAGR of 13.2% from 2019- Pre and Post COVID-19 Market Opportunity Analysis and Industry Forecasts by Meticulous Research®
June 22, 2020 10:36 ET
|
Meticulous Market Research Pvt. Ltd.
London, June 22, 2020 (GLOBE NEWSWIRE) -- POC molecular diagnostics include portable devices and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood,...
Avricore’s HealthTab™ Coming to 11 New Community Pharmacy Locations
November 28, 2019 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 28, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it will be placing HealthTab™...
Ontario Pharmacists and Avricore Health Partner to Expand HealthTab™ in Community Pharmacies and Enhance Patient Care
November 18, 2019 08:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are...